OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients
Marco Zuin, Gianluca Rigatelli, Claudio Bilato, et al.
Journal of Interventional Cardiac Electrophysiology (2021) Vol. 62, Iss. 2, pp. 231-238
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Impact of COVID-19 on Cardiovascular Disease
Ivan Vosko, Andreas Zirlik, Heiko Bugger
Viruses (2023) Vol. 15, Iss. 2, pp. 508-508
Open Access | Times Cited: 63

Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 33

Fibrinaloid Microclots and Atrial Fibrillation
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
(2024)
Open Access | Times Cited: 4

Fibrinaloid Microclots and Atrial Fibrillation
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
Biomedicines (2024) Vol. 12, Iss. 4, pp. 891-891
Open Access | Times Cited: 4

Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysis
Marco Zuin, Luisa Ojeda‐Fernández, G Torrigiani, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1613-1620
Closed Access | Times Cited: 3

Association of atrial fibrillation with infectivity and severe complications of COVID‐19: A nationwide cohort study
Jin Park, Jae Il Shin, Dong‐Hyeok Kim, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2422-2430
Open Access | Times Cited: 16

Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients
Alessandro Maloberti, Cristina Giannattasio, Paola Rebora, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 12

The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19
Siddharth Agarwal, Muhammad Bilal Munir, Stavros Stavrakis, et al.
European Journal of Internal Medicine (2023) Vol. 111, pp. 127-129
Open Access | Times Cited: 7

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 6

Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19
Stjepan Jurisic, Mathis Komminoth, Atanas Todorov, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2925-2925
Open Access | Times Cited: 6

New-Onset Atrial Fibrillation in the Setting of COVID-19 Infection Is a Predictor of Mortality in Hospitalized Patients: CovAF-Study
Mariana S. Parahuleva, Lukas Harbaum, Nikolaos Patsalis, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3500-3500
Open Access | Times Cited: 6

The Trends in Atrial Fibrillation-Related Mortality before, during, and after the COVID-19 Pandemic Peak in the United States
Inon Dimri, Ariel Roguin, Nashed Hamuda, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4813-4813
Open Access | Times Cited: 1

COVID-19 patients with acute pulmonary embolism have a higher mortality risk: systematic review and meta-analysis based on Italian cohorts
Marco Zuin, Gianluca Rigatelli, Claudio Bilato, et al.
Journal of Cardiovascular Medicine (2022) Vol. 23, Iss. 12, pp. 773-778
Open Access | Times Cited: 7

Preadmission Oral Anticoagulation for Atrial Fibrillation/Flutter and Death or Thrombotic Events During COVID-19 Admission
David W. Louis, Kevin F. Kennedy, Marwan Saad, et al.
The American Journal of Cardiology (2022) Vol. 181, pp. 38-44
Open Access | Times Cited: 5

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19
Steven Deitelzweig, Julia Zhu, Jenny Jiang, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 11, pp. 1891-1896
Closed Access | Times Cited: 4

Arterial Hypertension, Heart Failure, Angina Pectoris, Myocardial Infarction, and Atrial Fibrillation after COVID-19: A Narrative Review
Dulce Brito, Daniel Caldeira, Catarina Gregório, et al.
Heart and Mind (2024) Vol. 8, Iss. 2, pp. 81-88
Open Access

Pre-Existing Atrial Fibrillation in Hospitalized Patients with COVID-19: Insights from the CARDIO COVID 19–20 Registry
Wikler Bernal Torres, Juan Pablo Arango-Ibañez, Juan Manuel Montero Echeverri, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 210-210
Open Access

A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19
Nan‐Nan Shen, Jialiang Wang, Xinwen Liu, et al.
PeerJ (2024) Vol. 12, pp. e18330-e18330
Open Access

Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation
Vincenzo Russo, Angelo Silverio, Fernando Scudiero, et al.
Medicina (2022) Vol. 58, Iss. 3, pp. 399-399
Open Access | Times Cited: 3

Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry
Stefano Fumagalli, Caterina Trevisan, Susanna Del Signore, et al.
Aging Clinical and Experimental Research (2021) Vol. 34, Iss. 1, pp. 249-256
Open Access | Times Cited: 4

A Case of Hemorrhagic Cholecystitis in a Patient on Apixaban After COVID-19 Infection
Zohour Anouassi, Carlos Abril, Ghanem Ismail, et al.
American Journal of Case Reports (2023) Vol. 24
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top